Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZILA -- Ignore unavailable to you. Want to Upgrade?

To: Steven F. Woolf who wrote (774)	11/10/1998 6:32:00 PM
From: amiles	Respond to of 897

the small cap mkt might work for us now, heating up as it is... fund mgrs prowling to buy, might stumble across this one... price was lots higher 6 months ago with less to show for it than now...

To: Steven F. Woolf who wrote (774)	11/12/1998 6:13:00 PM
From: amiles	Read Replies (1) \| Respond to of 897

we seem to have a problem with the number 6, so in the interest of getting beyond that, let me propose "top 6 reasons to buy Zila:" 1. company sales growing, esp. Oxycal, independently of Oratest 2. Oratest on fast-track to FDA approval in USA 3. Oratest saves lives, will be darling of US health insurers 4. no near-term competition for Oratest 5. small cap mkt heating up 6. when the price on this thing does start to climb, it won't likely drop below 6 again